Global antifungal agents market is expected to grow at a moderate rate during the forecast period. This market includes drugs, powder, ointments, and pastes that are used to treat fungal infections. These antifungal agents prevent and destroy the growth of fungi that are responsible for various diseases such as aspergillosis, ringworm, skin infection and so forth. The antifungal drugs include azoles, polyenes, Echinocandins and allylamines. These drugs are widely used for the treatment of several fungal infections such as candidiasis, ringworm and tinea pedis. Increasing funding programs for the development of antifungal agents support in the effective treatment of fungal diseases. For instance, in June 2016, the Department of Molecular Genetics & Microbiology, Stony Brook University received a grant valued over $6.0 million from the National Institute of Health (NIH). This grant was intended to discover new approaches for the treatment of fungal infections based on collaborative and laboratory research along with experts, globally. They will collaborate for the development of the new class of antifungal agents. According to the experts, systemic fungal infections cause over one million fatalities each year. In addition, the treatment of such conditions is generally not effective coupled with drug resistance or toxicity. Thus, the funding from NIH enables recognizing the widespread requirement for potential antifungal treatments. As a result, it enables to drive the growth of the global antifungal agents market.
To Request a Sample of our Report on Antifungal Agents Market: https://www.omrglobal.com/request-sample/antifungal-agents-market
Moreover, other factors that are contributing towards the growth of antifungal agents market include rising incidence and prevalence of fungal diseases, advances in antifungal agents and increasing demand for azole class of drugs. However, adverse effects associated with antifungal drugs and stringent government regulations are creating hurdles in the market growth. The market is offering significant growth opportunities due to improving healthcare infrastructure and growing awareness about fungal infections. The global antifungal agents market has been segmented on the basis of application, drug-class, type and route of administration. According to drug-class, the market is further classified into polyenes, echinocandins, allylamines, azoles and others (flucytosine, griseofulvin and tolnaftate). Azoles class of drugs is gaining a significant position as it is one of the most preferred options for the treatment of systemic fungal infections. Based on the type, the market is classified into powders, ointments, drugs and pastes. According to the route of administration, the market is further classified into parenteral, topical and oral. Topical antifungals are considered as an essential adjuvant to treat dermatophytoses. Moreover, in certain conditions, including dermatophytoses in infants and pregnancy usually warrant topic therapy. This enables to drive the demand for topical antifungals.
Furthermore, the market is classified on the basis of geography, such as North America, Europe, and Asia Pacific & RoW. North America is expected to witness significant share in the global antifungal agents market due to increasing prevalence of fungal infections in the region. However, APAC is expected to hold a remarkable position in near future due to improving healthcare infrastructure and prevalence of invasive fungal infections in the countries, including China and India.
(Get 15% Discount on Buying this Report)
A full Report Antifungal Agents Market is Available at: https://www.omrglobal.com/industry-reports/antifungal-agents-market
Global Antifungal Agents Market Segmentation
By Drug Class
- Polyene
- Echinocandins
- Allylamines
- Azole
By dosage type
- Powders
- Ointments
- Drugs
- Paste
By Route of Administration
- Parenteral
- Topical
- Oral
Competitive Landscape
- Key Company Analysis
- Key Strategy Analysis
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of The World
- Latin America
- Middle East & Africa
Company Profiles
- Abbott Laboratories, Inc.
- Amplyx Pharmaceuticals, Inc.
- Astellas Pharma, Inc.
- Basilea Pharmaceutica AG
- Bayer Healthcare LLC
- Bristol-Myers Squibb Pharmaceuticals, Ltd.
- Cosmo Pharmaceuticals NV
- Gilead Sciences, Inc.
- Janssen Pharmaceutica NV
- Mayne Pharma, Inc.
- Merck & Co., Inc.
- Mylan Pharmaceuticals, Inc.
- Nouvasant Pharmhealth Ltd.
- Pfizer, Inc.
- Sanofi-Aventis U.S. LLC
- Scynexis, Inc.
- Sumitomo Dainippon Pharma Co., Ltd.
- Sun Pharmaceutical Industries, Ltd.
- Teva Pharmaceutical Industries, Ltd.
- Zydus Cadila Healthcare Ltd.
Reasons for Buying from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antifungal-agents-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
